// App-Quantinova.ai

144 : Prognostic role of docetaxel-induced reduction of free testosterone serum levels in metastatic prostate cancer patients.

Researchers

Presenter

  • Paula Kappler

Principal Investigators

  • Stefan Brunotte

  • Philipp Ivanyi

  • Michael A. Morgan

  • Christoph W. Reuter

Medical Centers

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • Department of Experimental Hematology, Hannover Medical School, Hannover, Germany

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved